[Skip to content]

Private Healthcare UK
Search our Site

This website is certified by Health On the Net Foundation. Click to verify.
This site complies with the HONcode standard for trustworthy health information:
verify here.


Leading supplier to the UK's audiology industry announces that Widex is finally going direct

PC Werth
After a period of amicable negotiation, PC Werth has announced that Widex A/S of Denmark is finally going direct to market. Widex will form its own subsidiary company to distribute and service its products in the UK from the summer of 2010, as it already has in many other markets worldwide.


“Widex is a superb Company”, says PC Werth Managing Director, Lawrence Werth, “and we have had 54 mutually rewarding years as their UK distributor. But over the last 2 or 3 years, with margins tightening and unprecedented adverse foreign exchange rates, it has proved impossible for us to achieve a satisfactory return.”


“Going direct with its own UK operation is the only sensible strategy for Widex” he adds.

“Indeed, it is the last of the major hearing aid manufacturers to establish a UK subsidiary, and we are sure that they will make a success of it.


“Inevitably, we will have to restructure our business at PC Werth, and we trust that our customers will appreciate the pressures this puts upon our staff over the coming months. However, this restructuring will enable us to now focus on what has always been the true strength of PC Werth: our depth and breadth of knowledge in the audiological market. Indeed, PC Werth has always described itself as ‘The UK's Leading Supplier to the UK's Audiology Industry.’


“There is a healthy market”, he continues, “for all the ancillary products and services needed by hearing aid manufacturers, retailers and end-users. With our expertise, reputation and contacts, we are well placed to further develop this market. That’s our future – and it’s a very bright one for PC Werth. So that’s where we are going to focus all our considerable energy and expertise.”

Private treatment news : 11 March 2010